Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,446.90
24.8 (1.74%)
BSENSE

Jun 18

BSE+NSE Vol: 9.58 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
33,653.08
31,723.73
29,001.87
24,855.38
23,455.49
24,774.63
23,098.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
33,653.08
31,723.73
29,001.87
24,855.38
23,455.49
24,774.63
23,098.50
Raw Material Cost
10,305.19
10,736.76
10,776.14
9,652.51
7,371.83
8,317.27
7,724.98
Purchase of Finished goods
3,477.98
2,887.11
2,772.93
2,050.43
1,951.77
2,315.42
2,112.11
(Increase) / Decrease In Stocks
-294.81
-597.63
-946.17
-409.68
816.68
-730.21
-101.86
Employee Cost
5,190.17
4,475.62
3,922.94
3,522.25
3,450.92
3,535.02
3,219.18
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
8,128.82
7,639.08
6,633.03
6,321.23
5,477.52
6,003.72
5,319.49
Total Expenditure (Excl Depreciation)
26,807.35
25,140.94
23,158.87
21,136.74
19,068.72
19,441.22
18,273.90
Operating Profit (PBDIT) excl Other Income
6,845.73
6,582.79
5,843.00
3,718.64
4,386.77
5,333.41
4,824.60
Other Income
492.09
621.85
557.38
290.59
320.35
380.84
86.20
Operating Profit (PBDIT)
7,337.82
7,204.64
6,400.38
4,009.23
4,707.12
5,714.25
4,910.80
Interest
383.97
457.24
289.71
140.48
48.64
74.49
159.77
Exceptional Items
-65.33
0.00
-191.86
0.00
-127.97
2,814.58
-26.13
Gross Profit (PBDT)
6,888.52
6,747.40
5,918.81
3,868.75
4,530.51
8,454.34
4,724.90
Depreciation
1,778.19
1,649.42
1,521.66
1,244.58
1,126.52
1,055.38
966.71
Profit Before Tax
5,110.33
5,097.98
4,397.15
2,624.17
3,403.99
7,398.96
3,758.19
Tax
1,608.88
1,582.72
1,211.02
684.85
725.63
2,009.77
913.51
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,501.45
3,515.26
3,186.13
1,939.32
2,678.36
5,389.19
2,844.68
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,501.45
3,515.26
3,186.13
1,939.32
2,678.36
5,389.19
2,844.68
Share in Profit of Associates
1.52
-31.69
-17.16
-11.67
-31.25
-55.36
-15.17
Minority Interest
1.78
2.31
4.00
-0.15
1.04
1.02
1.46
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,504.75
3,485.88
3,172.97
1,927.50
2,648.15
5,334.85
2,830.97
Equity Capital
58.08
58.08
58.59
58.59
58.59
58.59
58.59
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
37,832.89
32,595.24
29,784.21
26,781.26
24,517.39
21,871.27
16,766.07
Earnings per share (EPS)
60.34
60.02
54.16
32.9
45.2
91.05
48.32
Diluted Earnings per share
60.34
59.81
54.16
32.9
45.19
91.04
48.32
Operating Profit Margin (Excl OI)
20.51%
20.98%
20.36%
15.11%
18.77%
21.72%
21.22%
Gross Profit Margin
20.63%
21.5%
20.62%
15.72%
19.39%
34.43%
20.78%
PAT Margin
10.49%
11.1%
11.04%
7.83%
11.33%
21.72%
12.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 6.08% vs 9.39% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 0.54% vs 9.86% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 3.99% vs 12.66% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -16.02% vs 57.83% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Aurobindo Pharma With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
33,653.08
14,277.64
19,375.44
135.70%
Other Operating Income
0.00
0.00
0.00
Total Operating income
33,653.08
14,277.64
19,375.44
135.70%
Raw Material Cost
10,305.19
2,288.03
8,017.16
350.40%
Purchase of Finished goods
3,477.98
1,727.97
1,750.01
101.28%
(Increase) / Decrease In Stocks
-294.81
36.12
-330.93
-916.20%
Employee Cost
5,190.17
3,183.90
2,006.27
63.01%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
8,128.82
3,424.21
4,704.61
137.39%
Total Expenditure (Excl Depreciation)
26,807.35
10,660.23
16,147.12
151.47%
Operating Profit (PBDIT) excl Other Income
6,845.73
3,617.41
3,228.32
89.24%
Other Income
492.09
358.79
133.30
37.15%
Operating Profit (PBDIT)
7,337.82
3,976.20
3,361.62
84.54%
Interest
383.97
639.28
-255.31
-39.94%
Exceptional Items
-65.33
-129.75
64.42
49.65%
Gross Profit (PBDT)
6,888.52
3,207.17
3,681.35
114.78%
Depreciation
1,778.19
886.18
892.01
100.66%
Profit Before Tax
5,110.33
2,320.99
2,789.34
120.18%
Tax
1,608.88
394.58
1,214.30
307.74%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
3,501.45
1,926.41
1,575.04
81.76%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
3,501.45
1,926.41
1,575.04
81.76%
Share in Profit of Associates
1.52
11.69
-10.17
-87.00%
Minority Interest
1.78
-25.17
26.95
107.07%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,504.75
1,912.93
1,591.82
83.21%
Equity Capital
58.08
41.28
16.80
40.70%
Face Value
1.00
1.00
0.00
Reserves
37,832.89
16,259.06
21,573.83
132.69%
Earnings per share (EPS)
60.34
46.34
14.00
30.21%
Diluted Earnings per share
60.34
46.28
14.06
30.38%
Operating Profit Margin (Excl OI)
20.51%
25.34%
0.00
-4.83%
Gross Profit Margin
20.63%
22.46%
0.00
-1.83%
PAT Margin
10.49%
13.57%
0.00
-3.08%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 33,653.08 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.08% vs 9.39% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 3,504.75 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 0.54% vs 9.86% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6,845.73 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 3.99% vs 12.66% in Mar 2025

Annual - Interest
Interest 383.97 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -16.02% vs 57.83% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.51%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."